Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Harvard Business School
Merck
Mallinckrodt
Farmers Insurance
US Department of Justice

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 5,846,534

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,846,534
Title: Antibodies to the antigen campath-1
Abstract:An antibody is produced, which will bind effectively with the antigen Campath-1, and which has at least one complementarity determining region of rat origin, as identified in FIG. 2, which may be combined with a range of different foreign variable domain framework regions as desired, including framework regions of human origin.
Inventor(s): Waldmann; Herman (Cambridge, GB), Clark; Michael R. (Cambridge, GB), Winter; Gregory P. (Cambridge, GB), Riechmann; Lutz (La Jolla, CA)
Assignee: British Technology Group Limited (London, GB)
Application Number:08/235,705
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,846,534
Patent Claims:see list of patent claims

Details for Patent 5,846,534

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 001 2001-05-07   Try a Free Trial British Technology Group Limited (London, GB) 2015-12-08 RX Orphan company
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 002 2001-05-07   Try a Free Trial British Technology Group Limited (London, GB) 2015-12-08 RX Orphan company
Genzyme LEMTRADA alemtuzumab INJECTABLE;INJECTION 103948 003 2001-05-07   Try a Free Trial British Technology Group Limited (London, GB) 2015-12-08 RX Orphan company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Mallinckrodt
Argus Health
Cipla
Moodys
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.